NCT01407848View on ClinicalTrials.gov

Trial on Treatment With Inhaled Furosemide of Preterm and Term Neonates With Transient Tachypnoea

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Transient Tachypnoea of the Newborn
Interventions
DRUG

Furosemide

Patients received nebulised Furosemide iv solution 1 mg/kg (4x/d) for max.3 consecutive days.

DRUG

Saline 0,9%

nebulised 0,9% saline 4x/d for max.3 days

Trial Locations (1)

50931

Children´s Hospital University of Cologne, Cologne

All Listed Sponsors
lead

University of Cologne

OTHER

NCT01407848 - Trial on Treatment With Inhaled Furosemide of Preterm and Term Neonates With Transient Tachypnoea | Biotech Hunter | Biotech Hunter